Blockchain Registration Transaction Record

AXIM Biotech Partners with VisionPlus for Korean Dry Eye Diagnostics

AXIM Biotechnologies partners with VisionPlus to distribute TearScan dry eye and allergy diagnostic tests in South Korea, enhancing ocular healthcare through advanced point-of-care technology.

This partnership addresses the growing global epidemic of Dry Eye Disease, which affects millions worldwide and has been exacerbated by increased screen time and environmental factors. For patients suffering from chronic eye discomfort, this collaboration means faster, more accurate diagnosis and personalized treatment options. The ability to differentiate between different types of dry eye and ocular allergies at the point of care represents a significant advancement in eye care, potentially reducing misdiagnosis and enabling more effective treatment strategies. In South Korea, where digital device usage is among the highest globally, this partnership could improve quality of life for countless individuals suffering from eye conditions that often go undiagnosed or improperly treated.